1. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson’s Disease
   Christine Schwienbacher et al, 2017, J Mol Neurosci CrossRef
2. Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.
   Maria Liguori et al, 2018, Hum Mol Genet CrossRef
3. The Neuroprotective Role of MiR-124-3p in a 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease via the Regulation of ANAX5
   Rui-Fang Dong et al, 2018, J. Cell. Biochem. CrossRef
4. Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease
   Shane V. Hegarty et al, 2018, Neuronal Signal. CrossRef
5. miR-494-3p modulates the progression of in vitro and in vivo Parkinson’s disease models by targeting SIRT3
   Lijiao Geng et al, 2018, Neuroscience Letters CrossRef
6. Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
   Natalia N. Nalivaeva et al, 2018, Front. Neurosci. CrossRef
7. Novel miRNA expression in the delta opioid signaling pathway mediated cell survivability in an in vitro model of ER stress
   M Erfath Thanjeem Begum et al, 2019, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
8. Bound polyphenol from foxtail millet bran exhibits an antiproliferative activity in HT-29 cells by reprogramming miR-149-mediated aerobic glycolysis
   Jiangying Shi et al, 2019, Journal of Functional Foods CrossRef
9. Meta‐analyses identify differentially expressed micrornas in Parkinson's disease
   Jessica Schulz et al, 2019, Ann Neurol CrossRef
10. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson’s disease
    Hisashi Uwatoko et al, 2019, Mol Brain CrossRef
11. Noncoding RNAs in neurodegeneration
    Evgenia Salta et al, 2017, Nat Rev Neurosci CrossRef
12. Effects of Physical Exercise on the Expression of MicroRNAs
    Franciele Cascaes da Silva et al, 2020, Journal of Strength and Conditioning Research CrossRef
13. MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax
    Xiaobo Yang et al, 2020, Metab Brain Dis CrossRef
14. Serum microRNA expression levels in Turkish patients with Parkinson’s disease
    Betul Ozdilek et al, 2020, International Journal of Neuroscience CrossRef
15. Effect of Dance on Postural Control in People with Parkinson’s Disease: A Meta-Analysis Review
    Heloisa Suzano de Almeida et al, 2020 CrossRef
16. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
    Hsiuying Wang, 2021, IJMS CrossRef
17. Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
    Shareen Singh et al, 2020, CN CrossRef
18. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
    Prashanth Gowda et al, 2021, Ageing Research Reviews CrossRef
19. Alzheimer’s Disease Diagnostics Using miRNA Biomarkers and Machine Learning
    Amy Xu et al, 2022, JAD CrossRef
20. Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
    Giulia Gentile et al, 2022, JPM CrossRef
21. Emerging Role of MicroRNA-30c in Neurological Disorders
    Manish Kumar et al, 2022, IJMS CrossRef
22. A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches
    Saima Owais et al, 2023, CNSNDDT CrossRef
23. Integrative gene expression analysis for the diagnosis of Parkinson’s disease using machine learning and explainable AI
    Nikita Bhandari et al, 2023, Computers in Biology and Medicine CrossRef
24. Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA
    Sanskriti Rai et al, 2023, Front. Neurosci. CrossRef
25. MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis
    Diane Guévremont et al, 2023, Sci Rep CrossRef
26. Understanding the (epi)genetic dysregulation in Parkinson's disease through an integrative brain competitive endogenous RNA network
    Piergiorge Rafael Mina et al, 2024, Mechanisms of Ageing and Development CrossRef
27. Effects of MicroRNAs and Long Non-coding RNAs on Beneficial Action of Exercise on Cognition in Degenerative Diseases: A Review
    Zhen Han et al, 2024, Mol Neurobiol CrossRef
28. Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progression
    Ahmed Abdelmonem Hemedan et al, 2024, iScience CrossRef
29. Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
    Ayesha Nisar et al, 2024, MedComm CrossRef
30. In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
    Stephen Tunmise Akanbi et al, 2025, Egypt J Med Hum Genet CrossRef